Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07408258
What this trial is testing

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
OncoC4, Inc. 20
Early research (Phase 1)Looking for participantsNCT07660432
What this trial is testing

SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd. 472
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Testing effectiveness (Phase 2)Study completedNCT02273739
What this trial is testing

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

Who this might be right for
Solid TumorGliomaAngioimmunoblastic T-cell Lymphoma+2 more
Celgene 21
Testing effectiveness (Phase 2)Study completedNCT00478101
What this trial is testing

Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain

Who this might be right for
Advanced Solid Cancers
Gachon University Gil Medical Center 2,006
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181
What this trial is testing

Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Early research (Phase 1)Looking for participantsNCT06801002
What this trial is testing

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

Who this might be right for
Solid Tumor
Jabez Bioscience, Inc 25
Early research (Phase 1)Study completedNCT00030095
What this trial is testing

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03311477
What this trial is testing

Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 9
Testing effectiveness (Phase 2)Study completedNCT03220854
What this trial is testing

SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx

Who this might be right for
Solid Tumor
Virginia Commonwealth University 5
Testing effectiveness (Phase 2)UnknownNCT04179656
What this trial is testing

The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

Who this might be right for
Solid TumorHER2 Gene MutationHER-2 Gene Amplification+1 more
Tianjin Medical University Second Hospital 100
Early research (Phase 1)Study completedNCT00389922
What this trial is testing

Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07061639
What this trial is testing

QLS5133 Monotherapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 212
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Early research (Phase 1)Study completedNCT02081495
What this trial is testing

DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 35
Early research (Phase 1)Study completedNCT01293630
What this trial is testing

A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sanofi 18
Testing effectiveness (Phase 2)Ended earlyNCT05580770
What this trial is testing

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05888831
What this trial is testing

BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 100
Large-scale testing (Phase 3)Looking for participantsNCT06401356
What this trial is testing

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Who this might be right for
Hematologic MalignancySolid TumorAdvanced Malignancies
Novartis Pharmaceuticals 50
Next Page